Qualifying Therapeutic Discovery Project Grants for the State of Arizona
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| AmpliMed Corporation | Development of small-molecule anti-cancer drugs | $ 244,479.24 | |
| Apthera, Inc. | NeuVax-adjuvant treatment for node positive breast cancer with low to intermediate HER2 | $ 244,479.25 | |
| Ardent Sound Inc. | Development of Ultrasound Therapy Device for Sebaceous and Sweat Gland Treatment | $ 244,479.25 | |
| Ascalon International Inc | IV Fenretinide | $ 106,406.50 | $ 138,072.74 |
| bioVidria, Inc. | Integrated platform for glycoform biomarker discovery | $ 47,799.50 | $ 114,302.50 |
| BLUE HORSE LABS, INC. | TGEN COLLABORATION: GENETIC RISK FACTORS FOR ALZHEIMER'S DISEASE (PHASE II) | $ 179,589.50 | $ 8,301.50 |
| Blue Horse Labs, Inc. | Oxidative stress markers in multiple matrices as biomarkers for disease | $ 7,160.00 | $ 88,697.00 |
| Calimmune, Inc. | Hematopoietic Stem Cell Therapy for HIV/AIDS Usifng RNAi to Reduce Expression of CCR5 | $ 244,479.25 | |
| Cancer Prevention Pharmaceuticals Inc | Eflornithine | $ 189,893.77 | $ 54,585.48 |
| Capstone Therapeutics Corp | AZX100 for Idiopathic Pulmonary Fibrosis (IPF) | $ 78,150.00 | $ 166,329.24 |
| Cold Plasma Medical Technologies | Harmonic Cold Plasma medical Technology for the Repair of Living Cells, Tissue and organs. | $ 244,479.25 | |
| Eye Care and Cure Corporation | Extra-Ocular Motility Monitor (EOMM) | $ 63,720.71 | |
| Eye Care and Cure Corporation | I-CORE | $ 53,221.15 | |
| Gary A Flynn PhD/Spacefill Enterprises LLC | Multi-targeted Kinase Inhibitors as Imaging and Therapeutic Agents | $ 27,000.00 | |
| High Throughout Genomics, Inc. | qNPA miRNA Development Project | $ 41,483.00 | $ 5,419.00 |
| High Throughput Genomics, Inc | Mid Density Platform Development Project | $ 73,830.00 | $ 79,962.00 |
| High Throughput Genomics, Inc | qBead Development Project | $ 67,940.00 | $ 38,392.00 |
| High Throughput Genomics, Inc | Fusin Gene-SNV Mutation Tests Development Project | $ 26,268.50 | $ 28,273.50 |
| High Throughput Genomics, Inc | Pathogen Assay Development Project | $ 11,131.00 | $ 23,394.00 |
| High Throughput Genomics, Inc | DLBCL & Cell of Orgin Development Project | $ 16,408.50 | $ 8,707.00 |
| High Throughput Genomics, Inc | qSelect Assay Archive Development Project | $ 16,026.50 | $ 41,378.50 |
| High Throughput Genomics, Inc | qNPA Platform Technology Development Project | $ 71,709.50 | $ 117,348.00 |
| High Throughput Genomics, Inc | Melanoma Screening Development Project | $ 20,359.50 | |
| High Throughput Genomics, Inc | Radiation Exposure Monitoring Assay Development Project | $ 13,797.00 | $ 2,081.00 |
| Hope Medical Enterprises, Inc | Treatment of Acute Myocardial Infarction | $ 17,542.28 | |
| Hope Medical Enterprises, Inc. | Treatment of Sickle Cell Disease | $ 3,250.00 | $ 36,907.86 |
| HumaGene Inc | Recombinant fibrogen & thrombin | $ 17,985.00 | $ 14,500.00 |
| InNexus Biotechnology, Inc. | DXL 625 | $ 116,760.00 | |
| INSYS Therapeutics, Inc | Fentanyl Sublingual Spray | $ 244,479.24 | |
| INSYS Therapeutics, Inc | Dronabinol Oral Solution | $ 244,479.25 | |
| Kinetic Muscles Inc | Neuro Telerehabilitation System | $ 221,667.65 | $ 22,811.59 |
| MedApps, Inc | Utilizing the MedApps System for Remotely Monitoring Clinical Drug Therapies | $ 244,479.24 | |
| MSDx Multiple Sclerosis Diagnostics, LLC | Biomarkers for Monitoring Multiple Sclerosis Patients - A Window into the Brain | $ 82,908.19 | $ 47,063.66 |
| MSDx, Inc | Biomarkers for Monitoring Multiple Sclerosis Patients - A window into the Brain | $ 74,700.00 | |
| PathoGene, LLC | Development of molecular assays for the identification and resistance profiling of MRSA. | $ 37,850.50 | |
| Protein Genomics | Engineered Small-Diameter Artery Grafts Using Synthesized Human Elastin | $ 120,342.50 | $ 124,136.75 |
| Provista Life Sciences, LLC | Fibrinogen and fibrin degradation product lung cancer assay | $ 137,175.27 | |
| Provista Life Sciences, LLC | Multivariate Breast Cancer Detection and Screening Assay | $ 221,153.46 | |
| Provista Life Sciences, LLC | Epigenetic Test for Alzheimer's Disease | $ 244,479.25 | |
| Provista Life Sciences, LLC | Lymphocyte Proliferation Test for Early Alzheimer's Detection | $ 180,664.68 | |
| Prugen IP Holdings Inc | Drug Bioavailability Enhancement Delivery System | $ 244,479.25 | |
| Rowpar Pharmaceuticals, Inc | Stabilized Chlorine Dioxide for Treatment & Prevention of Oral Candidiasis | $ 1,402.50 | $ 3,673.00 |
| Rowpar Pharmaceuticals, Inc | 0.5% Stabilized Chlorine Dioxide for the Treatment and Prevention for Gingivitis | $ 2,881.00 | $ 20,782.50 |
| SALUTARIS MEDICAL DEVICES, INC. | SMD-A | $ 244,479.24 | |
| Sensys Medical Inc | Non-invasive boold glucose monitor for the diagnosis & treatment of diabetes | $ 244,479.24 | |
| Southwest Scientific Editing & Consulting, LLC | Dietary supplements enhanced for biofavanoids and antioxidants to treat human disease | $ 2,850.00 | $ 26,200.00 |
| Susavion Biosciences, Inc | Discovery of Immunotherapeutic Drugs Against Viral Infections | $ 85,997.50 | $ 117,631.00 |
| Synbuild LLC | Kit for noninvasive early detection of pancreatic cancer | $ 11,157.12 | |
| SYNCARDIA SYSTEMS, INC. | COMPANION 2 DRIVER | $ 54,080.75 | |
| Thayer Medical Corporation | Inline acuator for pMDI medication delivery in ventilator circuits with 15 mm connection. | $ 66,050.50 | $ 112,333.50 |
| Transmed Oncology Inc | Pre-Clinical and Clinical Development of DNMT1 inhibiting Compounds | $ 70,784.50 | |
| Valley Fever Solutions, Inc. | Late Stage Valley Fever - Phase II | $ 244,479.25 | |
| Vomaris Innovations, Inc | The Use of Bioelectric Wound Care Devices for Improving Healthcare | $ 244,479.25 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
